People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xtl Biopharmaceuticals Ltd | — | Pharmaceuticals | Seed | $5.3M | $106.5M | 2017 |
David Hillel Kestenbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Hillel Kestenbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shlomo Shalev | 1 | 2 |
| Doron Hillel Turgeman | 1 | 1 |
| Jonathan Hillel Schapiro | 1 | 1 |
| Oded Hillel Nagar | 1 | 1 |
| Ossi Hillel Fain | 1 | 1 |
| David Hillel Bassa | 1 | 1 |
| Dobroslav Hillel Melamed | 1 | 1 |
| Joshua Hillel Levine | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.